DZ Bank’s Nuvation Bio NUVB Stock Holding History

DZ Bank’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-90,797	Closed	-$331K	–	1081
2024 Q1	$331K	Buy	+90,797	New	+$174K	﹤0.01%	810

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

DZ Bank's NUVB Position: Q2 2024 in Review

DZ Bank sold out of Nuvation Bio (NUVB) in Q2 2024, closing a stake of 90,797 shares — an estimated $331K sold.

DZ Bank first reported a position in NUVB in Q1 2024 and held it in 1 quarter. The position peaked at $331K in Q1 2024. 148 funds tracked by Wall St. Rank hold NUVB as of Q2 2024.

DZ Bank reported no remaining Nuvation Bio position as of Q2 2024 after selling out during the quarter.
DZ Bank sold 90,797 Nuvation Bio shares in Q2 2024, an estimated $331K.
DZ Bank first reported a position in Nuvation Bio in Q1 2024 and held it in 1 quarter.
DZ Bank's Nuvation Bio position peaked at $331K in Q1 2024.
148 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2024.

Based on DZ Bank's 13F filing for Q2 2024, filed 14 Aug 2024.